| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.044 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |